Who owns Impax Laboratories?

Key details on Impax Laboratories (Ticker: IPXL)

Who owns Impax Laboratories?

Is IPXL a good stock to own? Find out who bought Impax Laboratories, who sold Impax Laboratories (IPXL) stock, and who holds a large position in Impax Laboratories.

Fund Name Number of Shares Share Valuation As Of
OrbiMed Advisors 6.78M $317.68M March 31, 2015
BlackRock Fund Advisors 5.38M $247.08M June 30, 2015
Vanguard 4.92M $226.10M June 30, 2015
Visium Asset Management 3.40M $52.50M March 31, 2013
Franklin Resources 3.34M $153.43M June 30, 2015
Inves 3.31M $104.73M Dec. 31, 2014
Pennant Capital Management 3.20M $147.13M June 30, 2015
Wells Fargo & Company 2.71M $55.10M June 30, 2012
RS INVESTMENT MANAGEMENT 2.35M $59.09M Dec. 31, 2013
Wellington Management Company 2.23M $45.64M Dec. 31, 2012
STATE STREET CORPORATION 2.15M $98.78M June 30, 2015
FMR 1.87M $87.85M March 31, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.76M $80.93M June 30, 2015
Jennison Associates 1.72M $51.63M June 30, 2014
BlackRock Institutional Trust Company, N.A. 1.68M $77.21M June 30, 2015
TCW 1.66M $42.96M Sept. 30, 2012
ALLIANCEBERNSTEIN 1.61M $32.97M Dec. 31, 2012
DIMENSIONAL FUND ADVISORS 1.60M $75.17M March 31, 2015
Ameriprise Financial 1.60M $50.58M Dec. 31, 2014
CITADEL ADVISORS 1.52M $30.37M June 30, 2013
Apex Capital 1.49M $29.61M June 30, 2013
Ranger Investment Management 1.47M $30.22M Dec. 31, 2012

Who sold Impax Laboratories?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Trust Advisors June 30, 2011 1.57M $34.19M
FRIESS ASSOCIATES March 31, 2011 2.19M $55.70M